BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2026 6:07:04 AM | Browse: 36 | Download: 157
 |
Received |
|
2025-10-24 09:43 |
 |
Peer-Review Started |
|
2025-10-24 09:44 |
 |
First Decision by Editorial Office Director |
|
2025-11-19 10:57 |
 |
Return for Revision |
|
2025-11-19 10:57 |
 |
Revised |
|
2025-12-01 16:49 |
 |
Publication Fee Transferred |
|
2025-12-03 16:10 |
 |
Second Decision by Editor |
|
2026-02-02 02:51 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-03 01:36 |
 |
Articles in Press |
|
2026-02-03 01:36 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-03-17 05:51 |
 |
Publish the Manuscript Online |
|
2026-03-27 06:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
MassARRAY-based KRAS and GNAS hotspot mutation analysis of cystic fluid enables accurate classification of pancreatic cystic lesions
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen-Fei Diao, Ming Cui, Tian-Qi Chen, Jin-Heng Xiao, Sen Yang, Qing-Yuan Zheng, Rui-Yuan Xu, Xian-Lin Han and Ya Hu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences |
2023-I2M-2-002 |
| National High-Level Hospital Clinical Research Funding |
2022-PUMCH-D-001 |
| Peking Union Medical College Hospital Talent Cultivation Program |
UHB12625 |
| Milstein Medical Asian American Partnership (MMAAP) Foundation |
|
| Noncommunicable Chronic Diseases-National Science and Technology Major Project |
2025ZD0552402 |
|
| Corresponding Author |
Ya Hu, MD, Professor, Department of General Surgery, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China. huya@pumch.cn |
| Key Words |
Pancreatic cyst lesions; Cyst fluid analysis; KRAS; GNAS; MassARRAY |
| Core Tip |
Pancreatic cystic lesions (PCLs) are highly heterogenous, which included benign, pre-malignant and malignant lesions. Current diagnostic approaches for PCLs exhibit limited efficacy and accuracy. The implementation of MassARRAY-based KRAS and GNAS mutation analysis of pancreatic cystic fluids improves the precise identification of mucinous cysts and intraductal papillary mucinous neoplasms, thereby providing critical support for clinical decision-making. |
| Publish Date |
2026-03-27 06:07 |
| Citation |
Diao WF, Cui M, Chen TQ, Xiao JH, Yang S, Zheng QY, Xu RY, Han XL, Hu Y. MassARRAY-based KRAS and GNAS hotspot mutation analysis of cystic fluid enables accurate classification of pancreatic cystic lesions. World J Gastroenterol 2026; 32(13): 115710
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i13/115710.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i13.115710 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.